Spire Healthcare GroupCHIX:SPIL -1.03%75 Cyclically Adjusted PS Ratio is 0.66 as of Jul. 07, 2026, which is 16% below its 10-year median of 0.79. GuruFocus rates CHIX:SPIL with a GF Score™ of 75/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 359 Healthcare Providers & Services companies, Spire Healthcare Group ranks better than 67.41% on this metric.
The historical rank and industry rank for Spire Healthcare Group's Cyclically Adjusted PS Ratio or its related term are showing as below:
CHIX:SPIl'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.43 Med: 0.79 Max: 1.08
Current: 0.66
During the past 13 years, Spire Healthcare Group's highest Cyclically Adjusted PS Ratio was 1.08. The lowest was 0.43. And the median was 0.79.
CHIX:SPIl's Cyclically Adjusted PS Ratio is ranked better than 67.41% of 359
companies
in the Healthcare Providers & Services industry
Industry Median: 1.14
vs CHIX:SPIl: 0.66
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Spire Healthcare Group's adjusted revenue per share data of for the fiscal year that ended in Dec25 was £3.898. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is £3.31 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Spire Healthcare Group (CHIX:SPIl) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Spire Healthcare Group Cyclically Adjusted PS Ratio Related Terms
Spire Healthcare Group Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for Spire Healthcare Group's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group Cyclically Adjusted PS Ratio Chart
CHIX:SPIL vs HCA, THC, DVA: Cyclically Adjusted PS Ratio Comparison
For the Medical Care Facilities subindustry, Spire Healthcare Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's Cyclically Adjusted PS Ratio falls into.
Spire Healthcare Group Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 0.66 mean?
Spire Healthcare Group (CHIX:SPIL) has a Cyclically Adjusted PS Ratio of 0.66 as of Jul. 07, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Spire Healthcare Group and its competitors. This is 16% below median its historical median of 0.79. Over the past decade, Spire Healthcare Group's Cyclically Adjusted PS Ratio has ranged from 0.43 to 1.08. According to the industry distribution chart, Spire Healthcare Group ranks #117 out of 359 companies in the Healthcare Providers & Services industry, placing it in the top 32.6%.
Is Spire Healthcare Group's Cyclically Adjusted PS Ratio too high?
Spire Healthcare Group's current Cyclically Adjusted PS Ratio of 0.66 is 16% below median its 10-year median of 0.79. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 1.08. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.14. Spire Healthcare Group's value of 0.66 is 42.1% below this industry median. Based on the distribution chart, Spire Healthcare Group ranks #117 out of 359 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Spire Healthcare Group has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's Cyclically Adjusted PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #117 out of 359 companies for Cyclically Adjusted PS Ratio. This puts Spire Healthcare Group in the upper half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.14. Spire Healthcare Group's value of 0.66 is 42.1% below this benchmark. Historically, Spire Healthcare Group's own Cyclically Adjusted PS Ratio has ranged from 0.43 to 1.08 over the past decade. While the company's 10-year median is 0.79 vs. the industry median of 1.14, Spire Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.14, based on 359 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current Cyclically Adjusted PS Ratio of 0.66 is 42.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current Cyclically Adjusted PS Ratio is 0.66, which is 16% below median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (CHIX:SPIL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.17 — trading 19.9% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 0.66, which is 16% below median its 10-year median of 0.79 and 42.1% below the Healthcare Providers & Services industry median of 1.14. Spire Healthcare Group's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Spire Healthcare Group (CHIX:SPIL), the current Cyclically Adjusted PS Ratio is 0.66 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (CHIX:SPIL) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.17 is trading 19.9% below its estimated GF Value™ of £2.71.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for CHIX:SPIL:
Cyclically Adjusted PS Ratio: 0.66 (16% below median its 10-year median of 0.79)
GF Value™: £2.71 vs. price of £2.17 (19.9% below fair value)
Industry Position: 42.1% below the Healthcare Providers & Services median (#117 of 359)
No single metric tells the full story. See the CHIX:SPIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
75GF Score
Get the complete analysis for CHIX:SPIL
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SPIL has been successfully added to your 
